Delivery Order SPE2DB22D1106-SPE2DB24FFEN0

Award Date 7/29/24
Potential Completion Date 7/30/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,729.00, is for the procurement of EMGALITY 120 MG/ML PENML, a medical supply product. The contract has a completion date of February 10, 2025 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the pharmaceutical product EMGALITY 120 MG/ML PENML, with a ceiling value of $1,218.84 and a period of performance through May 23, 2025. The contract has a firm-fixed-price pricing type and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award is a delivery order valued at $1,770.26 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EMGALITY 120 MG/ML PENML, a prescription medication, with a completion date of June 11, 2025. The contract type is Firm Fixed Price. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
The U.S. government agency Defense Logistics Agency (DLA) awarded a $1,729.00 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the supply of EMGALITY 120 MG/ML PENML, a pharmaceutical product, with a period of performance through February 18, 2025. This contract award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EMGALITY 120 MG/ML PENML, a prescription medication. The contract is valued at $4,811.16 and has a firm fixed price pricing type. The contract is not set-aside and has an ultimate completion date of May 28, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,034.84 firm fixed-price delivery order contract is for the supply of EMGALITY 120 MG/ML PENML, a pharmaceutical product. The contract has an ultimate completion date of May 19, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of EMGALITY 120 MG/ML PENML, a medication, with a firm fixed price of $1,159.93 and a completion date of June 25, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of EMGALITY 120 mg/ml pre-filled injection pens. The contract has a ceiling value of $1,671.20 and a completion date of August 16, 2024. It is a firm fixed-price contract and was not set aside for any small business program. AmerisourceBergen has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,558.30 firm fixed-price delivery order contract is for the supply of EMGALITY 120 MG/ML PENML, a medication. The contract has a period of performance through May 16, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,113.47 firm fixed-price contract is for the delivery of EMGALITY 120 MG/ML PENML, a pharmaceutical product, with a completion date of January 27, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFEN0
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of EMGALITY 120 MG/ML PENML, a pharmaceutical product. The contract has a firm fixed price of $1,069.80 and a period of performance through July 30, 2024. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous federal contracts to provide a wide range of medical commodities, including specialty medications, generic drugs, vaccines, and medical supplies, to support military treatment facilities, veterans' hospitals, and other government healthcare programs. This contract is not set aside for any specific business category. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and $750,000, respectively, to deliver a comprehensive range of pharmaceutical and medical products to meet the healthcare needs of the U.S. government and its beneficiaries.

Generated 10/28/24, 9:55 AM